Conformation of neuropeptide Y receptor antagonists: Structural implications in receptor selectivity

Peptides

Volumn 24, Issue 7, 2003, Pages 1035-1043

  Jois, Seetharama D S ^a   Balasubramaniam, Ambikaipakan ^b  

^a NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^b UNIVERSITY OF CINCINNATI MEDICAL CENTER   (United States)

Author keywords

Beta turn; Helical structure; NMR; NPY peptide; Trifluoroethanol

Indexed keywords

BVD 10; BVD 15; NEUROPEPTIDE Y RECEPTOR ANTAGONIST; UNCLASSIFIED DRUG;

ARTICLE; BETA SHEET; CARBOXY TERMINAL SEQUENCE; CIRCULAR DICHROISM; MOLECULAR DYNAMICS; MOLECULAR MODEL; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PEPTIDE SYNTHESIS; PRIORITY JOURNAL; PROTEIN CONFORMATION; PROTEIN STRUCTURE; RECEPTOR SENSITIVITY;

EID: 0141518429     PISSN: 01969781     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0196-9781(03)00183-9     Document Type: Article

References (40)

1. Balasubramaniam A. Neuropeptide Y family of hormones: receptor subtypes and antagonists. Peptides. 18:1997;445-457.
2. 2 (BW1911U90). J. Med. Chem. 44:2001;1479-1482.
3. Balasubramaniam A., Grupp I., Srivastava L., Tatemoto K., Murphy R.F., Joffe S.N.et al. Synthesis of neuropeptide Y. Int. J. Pep. Protein Res. 29:1986;78-83.
4. 2-NH) scan of peptide YY (PYY) active site, PYY(22-36), for interaction with rat intestinal PYY receptors: development of analogues with potent in vivo activity in the intestine. J. Med. Chem. 43:2000;3420-3427.
5. Bax A., Davis D.G. MLEV-17-based two-dimensional homonuclear magnetization transfer spectroscopy. J. Magn. Reson. 65:1985;355-360.
6. Beck A., Jung G., Gaida W., Koppen H., Lang R., Schnorrenberg G. Highly potent and small neuropeptide Y agonist obtained by linking NPY1-4 via a spacer to α-helical NPY25-36. FEBS Lett. 244:1989;119-122.
7. Beck-Sickinger A.G., Gaida W., Schnorrenberg G., Jung G. Neuropeptide Y: identification of the binding site. Int. J. Pept. Protein Res. 36:1990;522-530.
8. Bolin K.A., Pitkeathly M., Miranker A., Smith L.J., Dobson C.M. Insight into a random coil conformation and an isolated helix: structural and dynamical characterization of the C-helix peptide. J. Mol. Biol. 261:1996;443-453.
9. Buck M. Trifluoroethanol and colleagues: cosolvents come of age. Recent studies with peptides and proteins. Q. Rev. Biophys. 31:1998;297-355.
10. Bystrov V.F. Spin-spin coupling and the conformational states of peptide systems. Prog. NMR Spectrosc. 10:1976;41-81.
11. Daniels AJ, Heyer D, Spaltenstein A. Peptide antagonists of neuropeptide Y: design, structure and pharmacological characterization. Neuropeptide Y and drug development; 1997. p. 127-55.
12. Daniels A.J., Mathews J.E., Slepetis R.J., Jansen M., Viveros O.H., Tadepalli A.et al. High-affinity neuropeptide Y receptor antagonists. Proc. Natl. Acad Sci. U.S.A. 92:1995;9067-9071.
13. Perczel A, Hollosi M. Turns. In: Fasman GD, editor. Circular dichroism and conformational analysis of biomolecules. New York: Plenum Press; 1996. p. 285-381.
14. Gehlert D.R. Multiple receptors for the pancreatic polypeptide (PP-fold) family: physiological implications. Proc. Soc. Exp. Biol. Med. 218:1998;7-22.
15. Hipskind P.A., Lobb K.L., Nixon J.A. Potent and selective 1,2,3 trisubstituted indole NPY Y-1 antagonists. J. Med. Chem. 40:1997;3712-3714.
16. Inui A. Neuropeptide Y feeding: are multiple subtypes involved? Trends Pharmacol. Sci. 20:1999;43-46.
17. Jois S.D.S., Hughes R., Siahaan T.J. Comparison of the solution conformations of a cell-adhesive peptide LBE and its reverse sequence EBL. J. Biomol. Struct. Dyn. 17:1999;429-444.
18. 2+ binding cyclic peptide derived from the α-subunit of LFA-1: inhibitor of ICAM-1/LFA-1-mediated T-cell adhesion. J. Pept. Res. 53:1999;18-29.
19. Kanatani A., Kanno T., Ishihara A., Hata M., Sakuraba A., Tanaka T.et al. The novel neuropeptide Y Y1 receptor antagonist J-104870: a feeding suppressant with oral viability. Biochem. Biophys. Res. Commun. 266:1999;88-91.
20. Kanno T., Kanatani A., Keen S.L.C., Arai-Otsuki S., Haga Y., Iwama T.et al. Different binding sites for the neuropeptide Y Y1 antagonists 1229U91 and J-104870 on human Y1 receptors. Peptides. 22:2000;405-413.
21. Koglin N., Zorn C., Beumer R., Cabrele C., Bubert C., Sewald N.et al. Analogues of neuropeptide Y containing b-aminocyclopropane carboxylic acids are the shortest linear peptides that are selective for the Y1 receptor. Angew. Chem. Int. Ed. 42:2003;202-205.
22. Kumar A., Wagner G., Ernst R.R., Wuthrich K. Buildup rates of the nuclear Overhauser effect measured by two-dimensional proton magnetic resonance spectroscopy. J. Am. Chem. Soc. 103:1981;3654-3658.
23. Leban J.J., Heyer D., Landavazo A., Matthews J., Aulabaugh A., Daniels A. Novel modified carboxy terminal fragments of neuropeptide Y with high affinity for Y2-type receptors and potent functional antagonism at a Y1-type receptor. J. Med. Chem. 38:1995;1157-1159.
24. Liu H., Banville D.L., Basus V.J., James T.L. Deriving accurate interproton distances from ROESY spectra with limited knowledge of scalar coupling constants via the carnival algorithm. An iterative complete-relaxation-matrix approach. J. Magn. Reson. 107:1995;51-59.
25. 1H spin-spin coupling constants in proteins Biochem. Biophys. Res. Commun. 113:1983;967-974.
26. Murakami Y., Hara H., Okdata T. 1,3-Disubstituted benzazepins as novel, potent selective neuropeptide Y Y1 receptor antagonists. J. Med. Chem. 42:1999;2621-2632.
27. Parker E.M., Babji C.K., Balasubramanian A., Burrier R.E., Guzzi M., Hamud F.et al. GR231118(1229U91) and other analogues of the C-terminus of the neuropeptide Y are potent neuropeptide Y1 receptor antagonists and neuropeptide Y4 receptor antagonists. Eur. J. Pharmacol. 349:1998;97-105.
28. Perczel A., Fasman G.D. Quantitative analysis of cyclic β-turn models. Protein Sci. 1:1992;378-395.
29. Perczel A., Park K., Fasman G.D. Analysis of the circular dichroism spectrum of proteins using the convex constraint algorithm: a practical guide. Anal. Biochem. 203:1992;83-93.
30. 1H NMR spectra of protein via double quantum filtering Biochem. Biophys. Res. Commun. 117:1983;479-485.
31. Rose G.D., Gierasch L.M., Smith J.A. Turns in peptides and proteins. Adv. Protein Chem. 37:1985;1-109.
32. Sutcliffe MJ. Structure determination from NMR data II. Computational approaches. In: Roberts GCK, editor. NMR of macromolecules: a practical approach. New York: Oxford University Press; 1993. p. 359-90.
33. Takebayashi Y., Koga H., Togami J., Inui A., Kurihara H., Koshiya K.et al. Design of the Y1-receptor selective cyclic peptide based on the C-terminal sequence of neuropeptide Y. J. Pept. Res. 56:2000;409-415.
34. Tatemoto K. Isolation and characterization of peptide YY (PYY), a candidate gut hormone that inhibits pancreatic exocrine secretion. Proc. Natl. Acad. Sci. 79:1982;2514-2518.
35. Tatemoto K., Carlquist M., Mutt V. Neuropeptide Y: a novel brain peptide with structural similarities to peptide YY and pancreatic polypeptide. Nature (London). 296:1982;659-660.
36. 10-helix. J. Am. Chem. Soc. 118:1996;2744-2745.
37. Waeber B., Aubert J.F., Corder R., Evequoz D., Nussberger J., Gaillard R.C.et al. Am. J. Hypertens. 1:1988;193-199.
38. Wishart D.S., Sykes B.D., Richards F.M. The chemical shift index: a fast and simple method for the assignment of protein secondary structure through NMR spectroscopy. Biochemistry. 31:1992;1647-1651.
39. Wüthrich K. NMR of proteins and nucleic acids. New York: Wiley; 1986.
40. Zukowska-Grojec Z., Karwatowska-Prokopczuk E., Rose W., Rone J., Movafagh S., Ji H.et al. Neuropeptide Y: a novel angiogenic factor from the sympathetic nerves and endothelium. Circ. Res. 83:1998;187-195.